BBNXBeta Bionics Inc.
$17.61
$0.21
(1.18%)
Pre-Market
EarningsJul 29
Mkt Cap$770.47M
Vol102.00
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders PR Newswire SAN DIEGO, July 1, 2026 SAN DIEGO, July 1, 2026 /PRNewswire/ --Johnson Fistel, PLLP is investigating potential...
PR Newswire
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders PR Newswire SAN DIEGO, June 22, 2026 SAN DIEGO, June 22, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential...
PR Newswire
Johnson Fistel Continues Investigation of Beta Bionics, Inc. (BBNX)
Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Beta Bionics, Inc. (NASDAQ: BBNX). The investigation concerns whether Beta Bionics or certain of its executive officers made false or misleading statements, or failed to disclose material...
Business Wire
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth PR Newswire SAN DIEGO, June 5, 2026 SAN...
PR Newswire
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel
Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors losses and whether they may be recovered under federal securities laws.What if I purchased Beta Bionics...
Business Wire
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc...
PR Newswire
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
Shareholder Rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breached fiduciary duties to shareholders. Beta Bionics is a commercial-stage medical device company, engages in...
Business Wire
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by Analysts
Shares of Beta Bionics, Inc. (NASDAQ:BBNX - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold re...
MarketBeat
Beta Bionics (NASDAQ:BBNX) Price Target Cut to $24.00 by Analysts at Leerink Partners
Leerink Partners decreased their price target on Beta Bionics from $25.00 to $24.00 and set an "outperform" rating on the stock in a research note on Wednesday...
MarketBeat
Beta Bionics (NASDAQ:BBNX) Shares Gap Up on Strong Earnings
Beta Bionics (NASDAQ:BBNX) Shares Gap Up on Earnings Beat...
MarketBeat
<
1
2
...
>
MSTR9
18
ORCL54
34
SPCX16
9Advertisement|Remove ads.